脑积水流器市场- 产品（瓣膜[可调节、固定]、导管）、程序（脑室腹膜、腰腹膜、心室心房、脑室胸膜）、年龄组（儿科、成人）、最终用途（医院、ASC） 、全球预测（2024 - 2032）

由于脑积水和相关神经系统疾病盛行率不断增加，2024-2032 年脑积水流器市场规模的复合年增长率可能为 3.5%。据报道，全世界每年约有 40 万名儿童被诊断出患有脑积水。脑积水（包括先天性和后天性脑积水）的发病率上升，特别是在儿童和老年族群中，正在增加分流装置的需求。诊断技术的进步和医疗保健提供者意识的提高也将有助于早期发现和治疗。

现代脑积水分流器采用增强材料和先进机制，具有更好的生物相容性、可靠性和易用性。可程式阀门和远端监控功能等创新也改善了患者的治疗效果和便利性，使这些设备对医疗保健专业人员更具吸引力。旨在完善分流技术和扩大应用的加强研发力度将促进市场成长。

该行业分为产品、程序类型、年龄层、最终用途和地区。

从产品来看，由于其有效性和功能性，脑积水导管领域的脑积水分流市场将在 2032 年之前显着成长。导管技术的进步，例如改进的材料和设计创新，也增强了生物相容性并降低了併发症的风险，进一步促进了其越来越多的采用。

腰腹腔手术类型细分市场的脑积水流量市场预计在 2024 年至 2032 年间产生大量收入，因为它们可以有效管理传统脑室腹腔分流术较不适合的情况。腰部腹腔 (LP) 分流器能够将脑脊髓液从腰部转移到腹腔，为液体管理提供了另一种方法，使其成为复杂病例中的一个有价值的选择。

由于医疗基础设施的快速改善和医疗技术投资的增加，到 2032 年，亚太地区脑积水流量产业规模将以复合年增长率大幅成长。随着一些国家正在加强其医疗保健系统并扩大获得先进治疗的机会，脑积水患者可以获得更多的专门护理。旨在改善医疗设施和补贴治疗费用的政府措施和医疗保健政策也将有助于推动区域市场的成长。

目录

第 1 章：方法与范围

第 2 章：执行摘要

第 3 章：产业洞察

• 产业生态系统分析
• 产业影响力
  • 成长动力
    • 先天性脑积水盛行率增加
    • 人们对脑积水手术治疗的认识不断提高
    • 脑积水治疗的报销范围
    • 老年人口增加
  • 产业陷阱与挑战
    • 新兴国家缺乏进行复杂神经外科手术的基础设施
    • 脑积水流手术和后续护理相关的高成本
• 成长潜力分析
• 监管环境
• 波特的分析
• PESTEL分析

第 4 章：竞争格局

• 介绍
• 公司市占率分析
• 公司矩阵分析
• 竞争定位矩阵
• 战略仪表板

第 5 章：市场估计与预测：按产品类型，2021 - 2032

• 主要趋势
• 脑积水瓣膜
  • 可调压力阀
  • 定压阀
• 脑积水导管
  • 标准导管
  • 抗菌导管

第 6 章：市场估计与预测：按程序类型，2021 - 2032 年

• 主要趋势
• 脑室腹膜
• 腰腹膜
• 心室房
• 脑室胸膜

第 7 章：市场估计与预测：按年龄组别划分，2021 - 2032

• 主要趋势
• 儿科
• 成人

第 8 章：市场估计与预测：按最终用途，2021 - 2032 年

• 主要趋势
• 医院
• 门诊手术中心

第 9 章：市场估计与预测：按地区，2021 - 2032

• 主要趋势
• 北美洲
  • 我们
  • 加拿大
• 欧洲
  • 德国
  • 英国
  • 法国
  • 西班牙
  • 义大利
  • 荷兰
  • 欧洲其他地区
• 亚太地区
  • 中国
  • 日本
  • 印度
  • 澳洲
  • 韩国
  • 亚太地区其他地区
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 拉丁美洲其他地区
• 中东和非洲
  • 南非
  • 沙乌地阿拉伯
  • 阿联酋
  • 中东和非洲其他地区

第 10 章：公司简介

• B. Braun Melsungen AG
• CHRISTOPH MIETHKE GMBH & CO. KG
• DESU MEDIKAL A.S.
• G. Surgiwear Ltd.
• Hpbio
• Integra LifeSciences Corporation
• Kaneka Medix Corp.
• Luciole Medical AG
• Medtronic plc
• Natus Medical Incorporated
• SOPHYSA
• TKB Corporation

Hydrocephalus shunt market size is likely to register a 3.5% CAGR from 2024-2032 driven by the increasing prevalence of hydrocephalus and related neurological conditions. As per reports, annually around 400,000 children worldwide are diagnosed with hydrocephalus. The rising incidence of hydrocephalus, including both congenital and acquired forms, particularly in pediatric and elderly populations, is boosting the demand for shunt devices. Advances in diagnostic techniques and increased awareness among healthcare providers will also contribute to earlier detection and treatment.

Modern hydrocephalus shunts feature enhanced materials and advanced mechanisms for better bio-compatibility, reliability, and ease of use. Innovations, such as programmable valves and remote monitoring capabilities are also offering improved patient outcomes and convenience, making these devices more attractive to healthcare professionals. Increased R&D efforts aimed at refining shunt technologies and expanding applications will add to the market growth.

The industry is segmented into product, procedure type, age group, end-use, and region.

Based on product, the hydrocephalus shunt market from the hydrocephalus catheters segment will record a significant growth rate through 2032 due to their effectiveness and functionality. Advancements in catheter technology, such as improved materials and design innovations are also enhancing bio-compatibility and reducing the risk of complications, further contributing to their increasing adoption.

Hydrocephalus shunt market from the lumboperitoneal procedure type segment is poised to generate substantial revenue between 2024 and 2032 owing to their effectiveness in managing conditions where traditional ventriculoperitoneal shunts are less suitable. The ability of lumboperitoneal (LP) shunts to divert cerebrospinal fluid from the lumbar region to the peritoneal cavity provides an alternative approach to fluid management, making them a valuable option in complex cases.

Asia Pacific hydrocephalus shunt industry size will grow at a substantial CAGR through 2032 attributed to the rapidly improving healthcare infrastructure and increased investments in medical technologies. As several countries are enhancing their healthcare systems and expanding access to advanced treatments, there is greater availability of specialized care for hydrocephalus patients. Government initiatives and healthcare policies aimed at improving medical facilities and subsidizing treatment costs will also help in driving the regional market growth.

Table of Contents

Chapter 1 Methodology & Scope

• 1.1 Market scope & definitions
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Base estimates & calculations
  • 1.3.1 Base year calculation
  • 1.3.2 Key trends for market estimation
• 1.4 Forecast model
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
  • 1.5.2 Data mining sources

Chapter 2 Executive Summary

• 2.1 Industry 360° synopsis

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Increasing prevalence of congenital hydrocephalus
    • 3.2.1.2 Growing awareness towards surgical treatment of hydrocephalus
    • 3.2.1.3 Availability of reimbursement coverage for hydrocephalus treatments
    • 3.2.1.4 Increasing geriatric population
  • 3.2.2 Industry pitfalls & challenges
    • 3.2.2.1 Lack of infrastructure for performing complex neurosurgeries in emerging countries
    • 3.2.2.2 High cost associated to hydrocephalus shunt surgery and follow-up care
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape
• 3.5 Porter's analysis
• 3.6 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

• 4.1 Introduction
• 4.2 Company market share analysis
• 4.3 Company matrix analysis
• 4.4 Competitive positioning matrix
• 4.5 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product type, 2021 - 2032 ($ Mn)

• 5.1 Key trends
• 5.2 Hydrocephalus valves
  • 5.2.1 Adjustable pressure valves
  • 5.2.2 Fixed pressure valves
• 5.3 Hydrocephalus catheters
  • 5.3.1 Standard catheters
  • 5.3.2 Antimicrobial catheters

Chapter 6 Market Estimates and Forecast, By Procedure type, 2021 - 2032 ($ Mn)

• 6.1 Key trends
• 6.2 Ventriculoperitoneal
• 6.3 Lumboperitoneal
• 6.4 Ventriculoatrial
• 6.5 Ventriculopleural

Chapter 7 Market Estimates and Forecast, By Age group, 2021 - 2032 ($ Mn)

• 7.1 Key trends
• 7.2 Pediatric
• 7.3 Adult

Chapter 8 Market Estimates and Forecast, By End-use, 2021 - 2032 ($ Mn)

• 8.1 Key trends
• 8.2 Hospitals
• 8.3 Ambulatory surgery centers

Chapter 9 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

• 9.1 Key trends
• 9.2 North America
  • 9.2.1 U.S.
  • 9.2.2 Canada
• 9.3 Europe
  • 9.3.1 Germany
  • 9.3.2 UK
  • 9.3.3 France
  • 9.3.4 Spain
  • 9.3.5 Italy
  • 9.3.6 Netherlands
  • 9.3.7 Rest of Europe
• 9.4 Asia Pacific
  • 9.4.1 China
  • 9.4.2 Japan
  • 9.4.3 India
  • 9.4.4 Australia
  • 9.4.5 South Korea
  • 9.4.6 Rest of Asia Pacific
• 9.5 Latin America
  • 9.5.1 Brazil
  • 9.5.2 Mexico
  • 9.5.3 Rest of Latin America
• 9.6 Middle East and Africa
  • 9.6.1 South Africa
  • 9.6.2 Saudi Arabia
  • 9.6.3 UAE
  • 9.6.4 Rest of Middle East and Africa

Chapter 10 Company Profiles

• 10.1 B. Braun Melsungen AG
• 10.2 CHRISTOPH MIETHKE GMBH & CO. KG
• 10.3 DESU MEDIKAL A.S.
• 10.4 G. Surgiwear Ltd.
• 10.5 Hpbio
• 10.6 Integra LifeSciences Corporation
• 10.7 Kaneka Medix Corp.
• 10.8 Luciole Medical AG
• 10.9 Medtronic plc
• 10.10 Natus Medical Incorporated
• 10.11 SOPHYSA
• 10.12 TKB Corporation